BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35941287)

  • 1. Immunotherapy in Ovarian Cancer.
    Siminiak N; Czepczyński R; Zaborowski MP; Iżycki D
    Arch Immunol Ther Exp (Warsz); 2022 Aug; 70(1):19. PubMed ID: 35941287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in ovarian cancer.
    Krishnan V; Berek JS; Dorigo O
    Curr Probl Cancer; 2017; 41(1):48-63. PubMed ID: 28169004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for Ovarian Cancer: Disappointing or Promising?
    Deng M; Tang F; Chang X; Liu P; Ji X; Hao M; Wang Y; Yang R; Ma Q; Zhang Y; Miao J
    Mol Pharm; 2024 Feb; 21(2):454-466. PubMed ID: 38232985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
    Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
    Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current advances in immunotherapy in ovarian cancer].
    Le Saux O; Dubois B; Stern MH; Terme M; Tartour E; Classe JM; Chopin N; Trédan O; Caux C; Ray-Coquard I
    Bull Cancer; 2020 Apr; 107(4):465-473. PubMed ID: 32089245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
    Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted immune therapy of ovarian cancer.
    Knutson KL; Karyampudi L; Lamichhane P; Preston C
    Cancer Metastasis Rev; 2015 Mar; 34(1):53-74. PubMed ID: 25544369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity and immune suppression in human ovarian cancer.
    Preston CC; Goode EL; Hartmann LC; Kalli KR; Knutson KL
    Immunotherapy; 2011 Apr; 3(4):539-56. PubMed ID: 21463194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in Ovarian Cancer.
    Wang W; Liu JR; Zou W
    Surg Oncol Clin N Am; 2019 Jul; 28(3):447-464. PubMed ID: 31079799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for gynecologic cancers.
    Liao JB
    Gynecol Oncol; 2016 Jul; 142(1):3-5. PubMed ID: 27242186
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment.
    Yang L; Ning Q; Tang SS
    J Immunol Res; 2022; 2022():8052212. PubMed ID: 35340585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
    Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
    Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine strategies for glioblastoma: progress and future directions.
    Jackson C; Ruzevick J; Brem H; Lim M
    Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy opportunities in ovarian cancer.
    Chu CS; Kim SH; June CH; Coukos G
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):243-57. PubMed ID: 18279065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in human colorectal cancer: Challenges and prospective.
    Sun X; Suo J; Yan J
    World J Gastroenterol; 2016 Jul; 22(28):6362-72. PubMed ID: 27605872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for esophageal cancer: a 2019 update.
    Schizas D; Charalampakis N; Kole C; Mylonas KS; Katsaros I; Zhao M; Ajani JA; Psyrri A; Karamouzis MV; Liakakos T
    Immunotherapy; 2020 Feb; 12(3):203-218. PubMed ID: 32208794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
    Blair AB; Murphy A
    Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for immunotherapy in soft tissue sarcoma.
    Tseng WW; Somaiah N; Engleman EG
    Hum Vaccin Immunother; 2014; 10(11):3117-24. PubMed ID: 25625925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the power of the immune system to target cancer.
    Lizée G; Overwijk WW; Radvanyi L; Gao J; Sharma P; Hwu P
    Annu Rev Med; 2013; 64():71-90. PubMed ID: 23092383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in Gynecologic Cancers: Are We There Yet?
    Pakish JB; Jazaeri AA
    Curr Treat Options Oncol; 2017 Aug; 18(10):59. PubMed ID: 28840453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.